Table 1. Details of curve notation used to classify dose–response data in CPDB.
| Group | Definition | Processing required | Number of tumour-tissue data sets a |
| * | Two or more dose groups showing a linear curve | None | 8180 |
| \ | Two or more dose groups showing a downward departure from linearity | Only the dose level displaying the highest tumour incidence was retained for TD50 calculation | 543 |
| / | Two or more dose groups showing an upward departure from linearity | None | 672 |
| Z | Two or more dose groups showing upward or downward departure from linearity | A column in the CPDB data file indicated the number of dose groups used when generating the TD50. The highest tested dose groups were removed until this number of dose groups was reached | 1147 |
| 0 | No dose effect or only a single dose group | Removed from the data set | 12 179 |
aNumber within the whole data set before the removal of negative authors’ call rows.